CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.88 +0.32 (+8.99%)
As of: Oct 20, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Long-Term Debt Issuances (2018)

Updated

CollPlant Biotechnologies (CLGN) recorded Long-Term Debt Issuances of $58,000 in the year ended Dec 31, 2018.

Analysis

CollPlant Biotechnologies (CLGN) Long-Term Debt Issuances (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 CollPlant Biotechnologies 4.68 Mn -17.68 Mn -456,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -2,000.00
API Access

CollPlant Biotechnologies Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CLGN&period=max&api_key=YOUR_API_KEY